Location History:
- Bresso, Milan, IT (1977)
- Milan, IT (1977)
Company Filing History:
Years Active: 1977
Title: Vittorio Ambrogi: Innovator in Pyrazine Derivatives
Introduction
Vittorio Ambrogi is a notable inventor based in Bresso, Milan, Italy. He has made significant contributions to the field of chemistry, particularly in the development of pyrazine derivatives. His work has led to the filing of multiple patents, showcasing his innovative approach to chemical compounds.
Latest Patents
Vittorio Ambrogi holds 2 patents related to pyrazine 4-oxide derivatives. His latest patents include compounds of the formula ##STR1##, wherein R.sup.1, R.sup.2, R.sup.3 are hydrogen, C.sub.1-6 alkyl or alkoxy, with at least one of R.sup.1, R.sup.2, and R.sup.3 being other than hydrogen. Additionally, R.sup.4 is carboxy, carbalkoxy, or a carboxamide group, or a pharmaceutically acceptable salt when R.sup.4 is carboxy. Another patent discloses compounds of the formula (I) ##STR1##, where at least one of R.sup.1, R.sup.2, and R.sup.3 is C.sub.1-6 alkyl and the others are hydrogen atoms. In this case, R.sup.4 is hydroxy or C.sub.1-6 alkoxy, or a salt of the compound wherein R.sup.4 is hydroxy with a pharmaceutically acceptable base. A typical compound is 2-carboxy-5-methylpyrazine 4-oxide.
Career Highlights
Vittorio Ambrogi is currently associated with Carlo Erba S.p.A., a company known for its focus on pharmaceutical and chemical products. His role in the company has allowed him to further his research and development efforts in innovative chemical compounds.
Collaborations
Throughout his career, Vittorio has collaborated with notable colleagues such as Willy Logemann and Raffaele Tommasini. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Vittorio Ambrogi is a distinguished inventor whose work in pyrazine derivatives has made a significant impact in the field of chemistry. His patents reflect his innovative spirit and dedication to advancing pharmaceutical science.